WillItSurvive

Sells templated market-sizing reports (TAM, CAGR, segmentation) for a few thousand dollars each.

Little protection left
Assessed 24 July 2026 · Evidence as of 24 July 2026
Not much stands between this business and its pressures.
On the recordSince 24 July 2026 · Checkable from 12 months out · Every call on the record Checkpoint: Maturation of its Cell and Gene Therapy Intelligence Platform, which could test whether it holds any exclusive data
The call

A small, self-funded report shop selling exactly the kind of output AI can now produce for free, with no data or client lock-in found to slow that.

Precedence Research makes statistical reports about market sizes and industry trends, then sells them to companies that need this data. These reports are straightforward to produce and increasingly easy for artificial intelligence to generate for free or nearly free, and dozens of other firms already sell similar products. The company claims it launched AI-powered tools in April 2026, but those announcements have not been verified by outside sources, and the entire market-research category faces a trust crisis after major firms like KPMG and Deloitte published reports with made-up citations and false data. If one of Precedence's own reports gets caught containing fabricated information, especially reports marketed as AI-generated, the firm's reputation could collapse in an industry already struggling with credibility.

Why
01
AI pressure: Generative AI models (e.g. ChatGPT, Claude) generating market-sizing reports on demand. Its whole product is a templated stats report, the exact output AI models can now generate for free in seconds. Could AI do the core job? Yes, likely.
02
Bigger players: Grand View Research, MarketsandMarkets, and other syndicated research firms. Dozens of similar firms already sell near-identical CAGR and TAM reports, undercutting on price and speed. Could a giant copy it? Yes, easily.
03
What protects it. None apparent: no proprietary data, no regulatory lock-in, no client contracts found beyond homepage testimonials.
What would change this call
A Precedence Research 'AI-Powered' report is publicly shown to contain fabricated citations or data. Would show the firm is vulnerable to the same trust collapse that hit KPMG and Deloitte.
Independent trade press or customer contracts confirm the Cell and Gene Therapy Intelligence Platform uses licensed or proprietary data. Would show the firm is building a real data moat rather than repackaging public sources.
Reported revenue or headcount figures from ZoomInfo, Datanyze, or Growjo converge or diverge sharply over the next year. Would show whether the firm is actually growing or shrinking amid AI-driven competition.
Key numbers
  • Reports priced $2,800 to $9,400 each (2026-07-06)
  • Headcount estimates range from 10 to 200 employees across sources (2026-07-22)
  • No funding rounds or external investors found (2026-07-22)
Named risks
  • Core templated report business is directly replicable by generative AI at near-zero cost. Severity: high
  • Sector-wide AI hallucination scandals (KPMG, Deloitte) could extend distrust to Precedence's own AI-branded reports. Severity: high
  • No proprietary data, regulatory shield, or integration lock-in identified as of 2026-07-22. Severity: medium
  • Revenue and headcount figures conflict across all third-party sources, undermining credibility. Severity: medium
  • Crowded commodity market of near-identical SEO report-mill competitors. Severity: medium
Rivals, as read in July 2026
RivalDirectionEvidence
Emergen ResearchcontestingNamed as direct comparable competitor by Datanyze, 2026-07-22
Research DimensionscontestingNamed as direct comparable competitor by Datanyze, 2026-07-22
Grand View ResearchcontestingSame SEO-driven statistical report-mill format criticized by IPVM since 2018-03-30
MarketsandMarketscontestingNamed alongside Precedence peers in IPVM's 2018-03-30 scam-research critique of the segment
Generative AI/LLM toolsgaining onLLMs can produce templated CAGR/TAM reports at near-zero cost as of 2026-07-22
Gartner, IDC, Big Fourlosing toEnterprise strategic-research budgets remain with larger incumbents; no barrier stops their entry into this segment
Questions people ask
Is Precedence Research profitable?
No audited financials are public. Revenue estimates from data brokers conflict wildly: Growjo and CompWorth cite about $11.6M (2026-07-22), ZoomInfo says under $5M (2026-07-06), and Datanyze says $4.2M, so profitability cannot be confirmed from available sources.
Could AI replace Precedence Research?
Its core product, templated CAGR/TAM market-sizing reports, is structurally close to what generative AI already produces cheaply. As of 2026-07-22 no proprietary data, regulatory shield, or integration lock-in was found, making the commodity report business highly exposed to AI substitution.
Who owns Precedence Research?
Precedence Research is privately held with no ticker, no disclosed funding rounds, and no external investors found as of 2026-07-22. It lists a single 'Founder & Curator,' Aman Singh, on its own site, an unverified vendor claim, suggesting a founder-led, self-funded firm.
How many employees does Precedence Research have?
Headcount estimates conflict across data brokers as of 2026-07-22: Clutch says 10-49, Datanyze says 77, ZoomInfo/LinkedIn say 51-200, and Growjo/CompWorth say 114 with 37% YoY growth. No primary-source headcount figure exists.
Who is Precedence Research's biggest competitor?
Datanyze names Emergen Research and Research Dimensions as direct comparables (2026-07-22). More broadly it competes with SEO-driven report mills like Grand View Research, MarketsandMarkets, and Fortune Business Insights, all selling near-identical 'market size to hit $X billion by 20XX' reports.
What is Precedence Q?
Precedence Q is a subscription real-time market intelligence platform with forecasting dashboards that Precedence Research announced via its own GlobeNewswire press release on 2026-04-10. As of 2026-07-22 no independent press coverage of the launch had been found.
Timeline
  • 2026-06-12Industry scandal: KPMG AI report found with 40 of 45 citations fabricated or unverifiable
  • 2026-05-28Rival Technologies study documents growing trust decline over AI-generated market research
  • 2026-04-20Precedence Research announces Cell and Gene Therapy Intelligence Platform (vendor press release)
  • 2026-04-15Precedence Research announces AI-Powered Market Intelligence Service (vendor press release)
  • 2025-11-02Precedence Research publishes AI Precedence advisory page positioning itself as AI consultant
  • 2025-10Deloitte Australia issues partial refund for government report over AI errors
  • 2025-07-23Rival Mordor Intelligence publishes analysis on hidden risks of AI-only market research
  • 2020Clutch lists Precedence Research founding year as 2020, conflicting with other sources
Revision history
24 July 2026
First assessed. Little protection left. The text above is fixed as of this date and is not edited afterwards.
In the same band
Sources